Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial

Published:2015-12 Issue:6 Volume:66 Page:945-950
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Sircar Dipankar,Chatterjee Soumya,Waikhom Rajesh,Golay Vishal,Raychaudhury Arpita,Chatterjee Suparna,Pandey Rajendra

Publisher

Elsevier BV

Subject

Nephrology

Reference30 articles.

1. Risk of macrovascular disease stratified by stage of chronic kidney disease in type 2 diabetic patients: critical level of the estimated glomerular filtration rate and the significance of hyperuricemia;Tanaka;Clin Exp Nephrol,2011

2. High levels of uric acid correlate with decline of glomerular filtration rate in chronic kidney disease;Satirapoj;J Med Assoc Thai,2010

3. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study;Ben-Dov;Nephrol Dial Transplant,2011

4. Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout;Gaffo;Core Evid,2009

5. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia;Sánchez-Lozada;Nephron Physiol,2008

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperuricemia and its related diseases: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2024-08-28

2. Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease;Antioxidants;2024-06-12

3. Association of serum uric acid with all-cause and cardiovascular mortality in chronic kidney disease stages 3–5;Nutrition, Metabolism and Cardiovascular Diseases;2024-06

4. Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials;Annals of Medicine;2024-05-13

5. Uric acid in health and disease: From physiological functions to pathogenic mechanisms;Pharmacology & Therapeutics;2024-04